Investigating the effect of the hydro alcoholic extract of the flower of Elaeagnus angustifolia L on the sexual performance of women

Investigating the effect of the hydro alcoholic extract of the flower of Elaeagnus angustifolia L on the sexual performance of women, a randomized clinical trial with a double-blind control

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230501058039N1

Enrollment

Registered

2023-05-06

Start date

2023-05-31

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased sexual performance in women. Hypoactive sexual desire disorder

Interventions

Intervention group: Intervention group: The drug used is the hydro alcoholic extract of Elaeagnus angustifolia L flower, which was prepared by the Soxhlet method by Eugene Sinapjoh Pharmaceutical Comp

Eligibility

Sex/Gender

Female

Age

18 Years to 54 Years

Inclusion criteria

Inclusion criteria: Married Having a constant sexual partner Healthy pelvic examination Age 18 to 54 Deficiency or loss of sexual desire caused by stress Normal and regular menstrual cycle Obtaining a score less than 28 from the sexual dysfunction questionnaire.

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding Menopause Oophorectomy Consumption of alcohol and tobacco Wife's sexual problem Getting any disease during the study The patient's unwillingness to continue Diabetes, kidney and liver diseases, hypothyroidism, cardiovascular-cerebrovascular disease, cancer, mental disorder with drug use, use of any contraceptive and hormone-based drugs that affect libido, such as androgens, anti-androgens, SSRI , tricyclic antidepressants, progestin's and a-blockers a

Design outcomes

Primary

Measure	Time frame
Comparison of changes in the total score and domains of the sexual function questionnaire (FSFI) after consuming the hydro alcoholic extract of Elaeagnus angustifolia L. Timepoint: The total score of the questionnaire will be checked before taking the medicine and 30 days after taking the medicine. Method of measurement: Rosen sexual function questionnaire.	—

Secondary

Measure	Time frame
Comparison of progesterone and estrogen hormone changes. Timepoint: The amount of hormones will be measured once at the beginning of the study and once after 30 days at the end of the study. Method of measurement: Monobind kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactGholamreza Abdoli

Kermanshah University of Medical Sciences

abdoli1354@gmail.com+98 83 3526 2052

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026